BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 25603439)

  • 1. Autologous serum eye drops for the treatment of ocular surface disease.
    Azari AA; Rapuano CJ
    Eye Contact Lens; 2015 May; 41(3):133-40. PubMed ID: 25603439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autologous serum for ocular surface diseases.
    Quinto GG; Campos M; Behrens A
    Arq Bras Oftalmol; 2008; 71(6 Suppl):47-54. PubMed ID: 19274411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Autologous serum-eye-drops for ocular surface disorders. A literature review and recommendations for their application].
    Geerling G; Hartwig D
    Ophthalmologe; 2002 Dec; 99(12):949-59. PubMed ID: 12478384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The application of autologous serum eye drops in severe dry eye patients; subjective and objective parameters before and after treatment.
    Jirsova K; Brejchova K; Krabcova I; Filipec M; Al Fakih A; Palos M; Vesela V
    Curr Eye Res; 2014 Jan; 39(1):21-30. PubMed ID: 24074049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of autologous serum and umbilical cord serum eye drops for dry eye syndrome.
    Yoon KC; Heo H; Im SK; You IC; Kim YH; Park YG
    Am J Ophthalmol; 2007 Jul; 144(1):86-92. PubMed ID: 17493572
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of standardized and quality-controlled cord blood serum eye drop therapy in the healing of severe corneal epithelial damage in dry eye.
    Versura P; Profazio V; Buzzi M; Stancari A; Arpinati M; Malavolta N; Campos EC
    Cornea; 2013 Apr; 32(4):412-8. PubMed ID: 22955120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood derived eye drops for the treatment of cornea and ocular surface diseases.
    Giannaccare G; Versura P; Buzzi M; Primavera L; Pellegrini M; Campos EC
    Transfus Apher Sci; 2017 Aug; 56(4):595-604. PubMed ID: 28844373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autologous serum eye drops for the treatment of dry eye diseases.
    Kojima T; Higuchi A; Goto E; Matsumoto Y; Dogru M; Tsubota K
    Cornea; 2008 Sep; 27 Suppl 1():S25-30. PubMed ID: 18813071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A study of refractory cases of persistent epithelial defects associated with dry eye syndrome and recurrent corneal erosions successfully treated with cyclosporine A 0.05% eye drops.
    Napoli PE; Braghiroli M; Iovino C; Demarinis G; Fossarello M
    Drug Des Devel Ther; 2019; 13():2001-2008. PubMed ID: 31354245
    [No Abstract]   [Full Text] [Related]  

  • 10. Sustained benefits of autologous serum eye drops on self-reported ocular symptoms and vision-related quality of life in Australian patients with dry eye and corneal epithelial defects.
    Mondy P; Brama T; Fisher J; Gemelli CN; Chee K; Keegan A; Waller D
    Transfus Apher Sci; 2015 Dec; 53(3):404-11. PubMed ID: 26626963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of severe chronic ocular graft-versus-host disease using 100% autologous serum eye drops from a sealed manufacturing system: a retrospective cohort study.
    Tahmaz V; Gehlsen U; Sauerbier L; Holtick U; Engel L; Radojska S; Petrescu-Jipa VM; Scheid C; Hallek M; Gathof B; Cursiefen C; Steven P
    Br J Ophthalmol; 2017 Mar; 101(3):322-326. PubMed ID: 27267447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allogeneic serum eye drops for the treatment of dry eye patients with chronic graft-versus-host disease.
    Na KS; Kim MS
    J Ocul Pharmacol Ther; 2012 Oct; 28(5):479-83. PubMed ID: 22731244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the clinical course of dry eye syndrome.
    Horwath-Winter J; Berghold A; Schmut O; Floegel I; Solhdju V; Bodner E; Schwantzer G; Haller-Schober EM
    Arch Ophthalmol; 2003 Oct; 121(10):1364-8. PubMed ID: 14557170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autologous serum eye drops for the treatment of severe dry eye in patients with chronic graft-versus-host disease.
    Ogawa Y; Okamoto S; Mori T; Yamada M; Mashima Y; Watanabe R; Kuwana M; Tsubota K; Ikeda Y; Oguchi Y
    Bone Marrow Transplant; 2003 Apr; 31(7):579-83. PubMed ID: 12692625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autologous serum eye drops for ocular surface disorders.
    Geerling G; Maclennan S; Hartwig D
    Br J Ophthalmol; 2004 Nov; 88(11):1467-74. PubMed ID: 15489495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of autologous serum eye drops with different diluents.
    Cho YK; Huang W; Kim GY; Lim BS
    Curr Eye Res; 2013 Jan; 38(1):9-17. PubMed ID: 22928476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined application of autologous serum eye drops and silicone hydrogel lenses for the treatment of persistent epithelial defects.
    Choi JA; Chung SH
    Eye Contact Lens; 2011 Nov; 37(6):370-3. PubMed ID: 21983552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of diquafosol sodium eye drops on tear film stability in short BUT type of dry eye.
    Shimazaki-Den S; Iseda H; Dogru M; Shimazaki J
    Cornea; 2013 Aug; 32(8):1120-5. PubMed ID: 23635860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antioxidant and inflammatory cytokine in tears of patients with dry eye syndrome treated with preservative-free versus preserved eye drops.
    Jee D; Park SH; Kim MS; Kim EC
    Invest Ophthalmol Vis Sci; 2014 Jul; 55(8):5081-9. PubMed ID: 24994869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Albumin eye drops for treatment of ocular surface diseases].
    Unterlauft JD; Kohlhaas M; Hofbauer I; Kasper K; Geerling G
    Ophthalmologe; 2009 Oct; 106(10):932-7. PubMed ID: 19813016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.